Market Overview

Anti-CD38 Antibody Pipeline Insight, 2018 Report - ResearchAndMarkets.com

Share:

The "Anti-CD38
Antibody -Pipeline Insight, 2018"
drug pipelines has been added
to ResearchAndMarkets.com's offering.

'Anti-CD38 Antibody - Pipeline Insight, 2018' report offers
comprehensive insights of the pipeline (under development) therapeutics
scenario and growth prospects across Anti-CD38 Antibody development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Descriptive coverage of pipeline development activities for Anti-CD38
Antibody - Pipeline therapeutics development coverage provides
descriptive product profiles including (but not limited to) drug
description, product development and R&D activities encompassing
clinical and pre-clinical studies, designations, collaborations,
licensing deals, grants, technologies and patent details.

Key Topics Covered:

1. Report Introduction

2. Anti-CD38 Antibody - Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Anti-CD38 Antibody

4. Comparative Analysis

5. Anti-CD38 Antibody Pipeline Products in Clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

6. Anti-CD38 Antibody Pipeline Products in Non-clinical Stages

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment: Active Products

  • Pipeline Assessment by Route of Administration
  • Pipeline Assessment by Stage and Route of Administration
  • Pipeline Assessment by Molecule Type
  • Pipeline Assessment by Stage and Molecule Type

8. Inactive Pipeline Products

  • Research and Development
  • Product Development Activities
  • Reason for dormancy/discontinuation

Companies Mentioned

  • ImmunoGen
  • Genmab
  • MorphoSys
  • Centrose
  • Eli Lilly
  • Xencor

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/j4hgqr/anticd38?w=4

View Comments and Join the Discussion!